Format

Send to

Choose Destination
Curr Psychiatry Rep. 2017 Aug 15;19(10):67. doi: 10.1007/s11920-017-0819-1.

Oxytocin and Anxiety Disorders: Translational and Therapeutic Aspects.

Author information

1
Department of Psychiatry, Lebanese University, Beirut, Lebanon. wjnaja@gmail.com.
2
Gharios Medical Center, Mount Lebanon Hospital, Hazmieh, Beirut, Lebanon. wjnaja@gmail.com.
3
Department of Psychiatry, Lebanese University, Beirut, Lebanon.
4
Gharios Medical Center, Mount Lebanon Hospital, Hazmieh, Beirut, Lebanon.

Abstract

PURPOSE OF REVIEW:

This review aims to evaluate the most recent literature examining the oxytocin (OXT) system's role in human anxiety by surveying various fields of preclinical and clinical research supporting this role, and queries whether the OXT system might be a target for novel anxiolytics.

RECENT FINDINGS:

Evidence from the diverse body of literature presented here, from translational research, genetic and neuroimaging studies, to clinical trials of intranasal (IN) OXT reveals a positive association. In addition, some moderators (e.g., sex, specificities to cues) of OXT's anxiolytic effects can have an important influence on its outcomes, awaiting further research. Evidence for the role of OXT in regulating anxiety is undeniable. We expect that the diverse particularities of the OXT system will help broaden our understanding of anxiety and stress-related disorders. We conclude that OXT promises an enticing treatment option for human anxiety disorders especially those associated with socio-emotional dysfunctions.

KEYWORDS:

Anxiety; Human; Oxytocin; PTSD; Rodent; Social anxiety

PMID:
28808909
DOI:
10.1007/s11920-017-0819-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center